{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:31:38Z","timestamp":1791181898395,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurologic.theclinics.com","mdconsult.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.ncl.2014.09.003","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T01:16:45Z","timestamp":1416964605000},"page":"101-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":210,"title":["Huntington Disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Praveen","family":"Dayalu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp.56.1.98","article-title":"Duration of illness in Huntington\u2019s disease is not related to age at onset","volume":"56","author":"Roos","year":"1993","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"10","key":"10.1016\/j.ncl.2014.09.003_bib2","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","article-title":"Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records","volume":"84","author":"Evans","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/mds.25717","article-title":"Multisource ascertainment of Huntington disease in Canada: prevalence and population at risk","volume":"29","author":"Fisher","year":"2014","journal-title":"Mov Disord"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes","volume":"72","author":"Macdonald","year":"1993","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.ncl.2014.09.003_bib5","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199405193302001","article-title":"A\u00a0worldwide study of the Huntington\u2019s disease mutation: the sensitivity and specificity of measuring CAG repeats","volume":"330","author":"Kremer","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3810\/pgm.2011.09.2466","article-title":"Exploring the correlates of intermediate CAG repeats in Huntington disease","volume":"123","author":"Ha","year":"2011","journal-title":"Postgrad Med"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1034\/j.1399-0004.2001.600305.x","article-title":"High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia","volume":"60","author":"Almqvist","year":"2001","journal-title":"Clin Genet"},{"issue":"2","key":"10.1016\/j.ncl.2014.09.003_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/318193","article-title":"Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases","volume":"68","author":"Falush","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/WNL.37.3.364","article-title":"Saccades in Huntington\u2019s disease: initiation defects and distractibility","volume":"37","author":"Lasker","year":"1987","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2014.09.003_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.870100213","article-title":"Functional decline in Huntington\u2019s disease","volume":"10","author":"Feigin","year":"1995","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2014.09.003_bib11","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jnnp-2013-305114","article-title":"Cognitive decline in prodromal Huntington disease: implications for clinical trials","volume":"84","author":"Paulsen","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1037\/0894-4105.13.3.381","article-title":"The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory","volume":"13","author":"Rohrer","year":"1999","journal-title":"Neuropsychology"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.45.5.951","article-title":"Distinct cognitive profiles of cortical and subcortical dementia in advanced illness","volume":"45","author":"Paulsen","year":"1995","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/13803390600718958","article-title":"Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities","volume":"29","author":"Hoth","year":"2007","journal-title":"J\u00a0Clin Exp Neuropsychol"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","article-title":"Neuropsychiatric aspects of Huntington's disease","volume":"71","author":"Paulsen","year":"2001","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1176\/ajp.140.6.728","article-title":"Psychiatric syndromes in Huntington\u2019s disease","volume":"140","author":"Caine","year":"1983","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.ncl.2014.09.003_bib17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib18","first-page":"192","article-title":"Longitudinal personality changes among presymptomatic Huntington disease gene carriers","volume":"15","author":"Kirkwood","year":"2002","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0022-3956(02)00054-7","article-title":"Evaluation of psychological symptoms among presymptomatic HD gene carriers as measured by selected MMPI scales","volume":"36","author":"Kirkwood","year":"2002","journal-title":"J\u00a0Psychiatr Res"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1176\/appi.neuropsych.17.4.496","article-title":"Depression and stages of Huntington's disease","volume":"17","author":"Paulsen","year":"2005","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ajmg.1320480412","article-title":"Risk-factors for suicide in Huntington\u2019s disease: a retrospective case-controlled study","volume":"48","author":"Lipe","year":"1993","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1086\/302374","article-title":"A\u00a0worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease","volume":"64","author":"Almqvist","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.2010.208264","article-title":"Longitudinal change in regional brain volumes in prodromal Huntington disease","volume":"82","author":"Aylward","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"7","key":"10.1016\/j.ncl.2014.09.003_bib25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1474-4422(13)70088-7","article-title":"Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data","volume":"12","author":"Tabrizi","year":"2013","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.ncl.2014.09.003_bib26","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: Cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.58.5.695","article-title":"Regional and progressive thinning of the cortical ribbon in Huntington's disease","volume":"58","author":"Rosas","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2014.09.003_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2014.09.003_bib30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1212\/WNL.0b013e3182648b65","article-title":"Measures of growth in children at risk for Huntington disease","volume":"79","author":"Lee","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.003_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/brain\/awq280","article-title":"Smaller intracranial volume in prodromal Huntington's disease: evidence for abnormal neurodevelopment","volume":"134","author":"Nopoulos","year":"2011","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington\u2019s disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib34","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","article-title":"Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease","volume":"65","author":"van Oostrom","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2014.09.003_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","article-title":"PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease","volume":"120","author":"Ginovart","year":"1997","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib36","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.ncl.2014.09.003_bib37","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1523\/JNEUROSCI.5599-08.2009","article-title":"In\u00a0vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease","volume":"29","author":"Heng","year":"2009","journal-title":"J\u00a0Neurosci"},{"issue":"5\u20136","key":"10.1016\/j.ncl.2014.09.003_bib38","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog Neurobiol"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington\u2019s disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res"},{"issue":"12","key":"10.1016\/j.ncl.2014.09.003_bib40","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/mds.25624","article-title":"Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia","volume":"28","author":"Reiner","year":"2013","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchemneu.2004.02.005","article-title":"Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study","volume":"27","author":"Deng","year":"2004","journal-title":"J\u00a0Chem Neuroanat"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington\u2019s disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann Neurol"},{"issue":"15","key":"10.1016\/j.ncl.2014.09.003_bib43","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ana.410270403","article-title":"Striatal and nigral neuron subpopulations in rigid Huntington\u2019s disease: implications for the functional-anatomy of chorea and rigidity-akinesia","volume":"27","author":"Albin","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2014.09.003_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/brain\/awl243","article-title":"Striosomes and mood dysfunction in Huntington's disease","volume":"130","author":"Tippett","year":"2007","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.ncl.2014.09.003_bib46","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/hmg\/2.10.1547","article-title":"Correlation between the onset age of Huntington\u2019s disease and length of the trinucleotide repeat in it-15","volume":"2","author":"Stine","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.ncl.2014.09.003_bib47","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jmg.31.11.872","article-title":"Trinucleotide repeat length and progression of illness in Huntington\u2019s disease","volume":"31","author":"Kieburtz","year":"1994","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical-features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1212\/WNL.44.6.1137","article-title":"CAG repeat size and clinical presentation in Huntington\u2019s disease","volume":"44","author":"Ashizawa","year":"1994","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2014.09.003_bib50","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/01.WNL.0000035627.16789.23","article-title":"Relationship between CAG repeat length and late-stage outcomes in Huntington's disease","volume":"59","author":"Marder","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2014.09.003_bib51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mds.24024","article-title":"Age, CAG repeat length, and clinical progression in Huntington's disease","volume":"27","author":"Rosenblatt","year":"2012","journal-title":"Mov Disord"},{"issue":"22","key":"10.1016\/j.ncl.2014.09.003_bib52","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","article-title":"Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS","volume":"80","author":"Killoran","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib53","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1073\/pnas.1221891110","article-title":"Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease","volume":"110","author":"Sathasivam","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"12","key":"10.1016\/j.ncl.2014.09.003_bib54","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.1074\/jbc.M109.075028","article-title":"Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease","volume":"285","author":"Landles","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol"},{"issue":"5334","key":"10.1016\/j.ncl.2014.09.003_bib56","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib57","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/mds.23685","article-title":"Milestones in Huntington disease","volume":"26","author":"Shoulson","year":"2011","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.ncl.2014.09.003_bib58","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"15","key":"10.1016\/j.ncl.2014.09.003_bib59","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"11","key":"10.1016\/j.ncl.2014.09.003_bib60","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1073\/pnas.95.11.6480","article-title":"Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene","volume":"95","author":"Cha","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib61","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"5529","key":"10.1016\/j.ncl.2014.09.003_bib62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol"},{"issue":"24","key":"10.1016\/j.ncl.2014.09.003_bib64","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1073\/pnas.0610628104","article-title":"Huntingtin facilitates dynein\/dynactin-mediated vesicle transport","volume":"104","author":"Caviston","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"7154","key":"10.1016\/j.ncl.2014.09.003_bib65","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington's disease","volume":"448","author":"Bennett","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.ncl.2014.09.003_bib66","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice","volume":"180","author":"Wang","year":"2008","journal-title":"J\u00a0Cell Biol"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib67","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","article-title":"The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation","volume":"34","author":"Wong","year":"2014","journal-title":"J\u00a0Neurosci"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat Neurosci"},{"issue":"7","key":"10.1016\/j.ncl.2014.09.003_bib69","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1 alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ncl.2014.09.003_bib72","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","article-title":"Early alterations of brain cellular energy homeostasis in Huntington disease models","volume":"287","author":"Mochel","year":"2012","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib73","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2014.09.003_bib74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q(10)","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib75","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1046\/j.1471-4159.1999.0721890.x","article-title":"Subtype-specific enhancement of NMDA receptor currents by mutant huntingtin","volume":"72","author":"Chen","year":"1999","journal-title":"J\u00a0Neurochem"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"10.1016\/j.ncl.2014.09.003_bib77","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib78","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"Ray","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib79","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Marshall","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2014.09.003_bib80","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1212\/WNL.59.5.694","article-title":"Huntington's disease - a randomized, controlled trial using the NMDA-antagonist amantadine","volume":"59","author":"Metman","year":"2002","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2014.09.003_bib81","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneur.60.7.996","article-title":"A\u00a0randomized trial of amantadine in Huntington disease","volume":"60","author":"O'Suilleabhain","year":"2003","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0303-8467(80)90017-7","article-title":"Seven cases of huntington\u2019s disease in childhood and levodopa induced improvement in the hypokinetic \u2013 Rigid form","volume":"82","author":"Jongen","year":"1980","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ncl.2014.09.003_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2377-6-11","article-title":"Dose-dependent improvement of myoclonic hyperkinesia due to valproic acid in eight Huntington's disease patients: a case series","volume":"6","author":"Saft","year":"2006","journal-title":"BMC Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2014.09.003_bib84","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.parkreldis.2011.10.021","article-title":"An evidence-based approach in the treatment of Huntington's disease","volume":"18","author":"Mestre","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib85","first-page":"180","article-title":"ACTION-HD: a randomized, double-blind, placebo-controlled prospective crossover trial investigating the efficacy and safety of bupropion in Huntington's disease","volume":"10","author":"Gelderblom","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"68","key":"10.1016\/j.ncl.2014.09.003_bib86","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-7091-0579-5_14","article-title":"The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease","author":"Beister","year":"2004","journal-title":"J\u00a0Neural Transm Suppl"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.wnf.0000240945.44370.f0","article-title":"Two years' follow-up of rivastigmine treatment in Huntington disease","volume":"30","author":"de Tommaso","year":"2007","journal-title":"Clin Neuropharmacol"},{"issue":"7","key":"10.1016\/j.ncl.2014.09.003_bib88","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/01.wnl.0000238106.10423.00","article-title":"Effect of donepezil on motor and cognitive function in Huntington disease","volume":"67","author":"Cubo","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2014.09.003_bib89","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3171\/JNS\/2008\/109\/7\/0130","article-title":"Long-term follow-up of Huntington disease treated by bilateral deep brain stimulation of the internal globus pallidus","volume":"109","author":"Biolsi","year":"2008","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.ncl.2014.09.003_bib90","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/jnnp.2009.202903","article-title":"Long-term follow-up of pallidal deep brain stimulation in two cases of Huntington's disease","volume":"82","author":"Kang","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatr"},{"issue":"2\u20133","key":"10.1016\/j.ncl.2014.09.003_bib91","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainresbull.2006.10.027","article-title":"Comprehensive care in Huntington's disease - a physician's perspective","volume":"72","author":"Nance","year":"2007","journal-title":"Brain Res Bull"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T08:20:49Z","timestamp":1538036449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861914000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0733861914000711"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2014.09.003","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huntington Disease","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2014.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}